Rhesus disease is the most common cause of anemia in unborn children. Although the condition is rare, treatment options are diverse. To gain insight into the differences in care, LUMC initiated a large global study. Together with 30 centers from 21 countries, the largest database of patients with rhesus disease was created. This provided a lot of new insights to improve care around this condition.
Read more&w=710&h=710)
Introduction
LUMC strongly underpins the idea that ‘Science is the driving force behind innovative healthcare’. Outcomes of top level fundamental, translational and clinical research by LUMC researchers form a strong basis for innovative and qualitative healthcare on a national, European and international level.
A real game changer was the development of the Dutch national research agenda (NWA) in 2015. The agenda reveals the complexity of the issues challenging Dutch society today. These issues are clustered in so called routes. LUMC is involved in many of these routes and contributes this way to solving important societal challenges.